Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.80
Delayed Data
As of Sep 22
 -0.10 / -3.45%
Today’s Change
1.10
Today|||52-Week Range
5.30
+107.41%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close2.90
Today’s open2.90
Day’s range2.75 - 2.94
Volume95,274
Average volume (3 months)143,066
Market cap$55.4M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+48.98%
Earnings growth (this year)+15.00%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+49.94%
P/E ratioNM
Price/Sales0.79
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
VRMLVermillion Inc+0.05+4.03%
GALTGalectin Therapeutic...+0.03+1.60%
TRILTrillium Therapeutic...+0.20+4.08%
IDXGInterpace Diagnostic...-0.08-5.37%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$27.0M
Annual profit (last year)-$15.8M
Net profit margin-58.42%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Chairman &
Chief Operating Officer
John A. Roberts
President, Chief Executive Officer &
Director
Panna L. Sharma
Corporate headquarters
Rutherford, New Jersey

Forecasts